Production of monoclonal antibody on a discontinuous perfusion microfluidic device

BOURGUIGNON N; ATTALLAH C; KARP P; BOOTH R; PEÑAHERRERA A; PAYÉS C; OGGERO M; PÉREZ M.; HELGUERA G.; LERNER.B

INTEGRATIVE BIOLOGY

ROYAL SOC CHEMISTRY

Lugar: CAMBRIDGE; Año: 2018 vol. 10 p. 136 - 144

1757-9694

Here is presented a discontinuous perfusion microfluidic device with cisterns design for cultivation of adherent eukaryotic cells for the production of recombinant proteins. The geometric configuration of the microchannels in the device provided laminar flow with reduced velocity profiles in the cisterns, resulting in an adequate microenvironment for long term adherent cell growth with passive pumping flow cycles of 24 hours. CHO-ahIFNα2b and HEK-ahIFNα2b adherent cell lines expressing a novel anti-hIFN-α2b recombinant monoclonal antibody (MAb) for treatment of Systemic Lupus Erythematosus were cultured on the surface of PDMS/glass microchannels coated with poly-D-lysine. A 24-days culture of CHO-ahIFNα2b cells resulted in MAb concentrations up to 166.4 μg mL-1 per day. The average productivity of anti-hIFN-α2b in CHO-ahIFNα2b and HEK-ahIFNα2b were 1.36 and 1.70 times higher, respectively, than those observed in T-flasks. Moreover, biological analysis of the MAbs produced in the microdevice showed no significant differences in the neutralizing antiproliferative activity of the hIFN-α2b or the cytokine cell signaling compared to the MAbs produced with standard methods. These results suggest that this microfluidic device is suitable for long term culture of mammalian cells and can improve the productivity of cells expressing recombinant MAbs with potential for therapeutic use without affecting their ability to bind to the cytokine and neutralize its activity.